News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
48.11
+0.49 (+1.03%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bristol-Myers Squibb
< Previous
1
2
3
4
5
6
7
8
9
...
46
47
Next >
Is Bristol-Myers Squibb's Stock Rally Justified? Bull Vs. Bear Analysts On Q2 Earnings
July 29, 2024
Bristol-Myers Squibb's stock rallies after Q2 results. Analysts have mixed views on the performance and management commentary.
Via
Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
July 29, 2024
Via
Benzinga
This Bristol-Myers Squibb Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
July 29, 2024
Via
Benzinga
Why I Loaded Up on This Ultra-High-Yielding ETF After the Nasdaq's Recent Slump
July 29, 2024
This ETF enables me to generate income and participate in the Nasdaq's upside potential.
Via
The Motley Fool
Topics
ETFs
Dow Jumps Over 650 Points Following Inflation Data: Fear & Greed Index Moves To 'Neutral' Zone
July 29, 2024
CNN Greed & Fear Index improved to Neutral zone on Friday, with U.S. stocks closing higher and Dow Jones jumping over 650 points on inflation data.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Bristol Myers Squibb Earnings Easily Beat On Cost Cuts; Stock Jumps
July 26, 2024
The drug giant also raised guidance.
Via
Investor's Business Daily
A Glimpse Into The Expert Outlook On Bristol-Myers Squibb Through 4 Analysts
July 22, 2024
Via
Benzinga
2 High-Yield Dividend Stocks That Could Shine in 2025
July 27, 2024
With interest rates expected to decline, high-yield dividend stocks offer attractive income potential and possible capital appreciation.
Via
The Motley Fool
Tech Stocks Slide On Earnings, US Economy Flexes Muscles, Small-Cap Rally Continues: This Week In The Markets
July 26, 2024
Tech earnings season disappoints investors with declines in Magnificent Seven stocks. Alphabet, Tesla miss targets, Nasdaq 100 falls 2nd week in a row.
Via
Benzinga
Topics
Economy
Exposures
Economy
Wall Street Enjoys Late-Week Rally On Benign Inflation Data, Dow Jones Eyes Best Session Of 2024, Tech Unwinding Stalls: What's Driving Markets Friday?
July 26, 2024
After a turbulent week in the markets, the bulls reclaimed dominance on Wall Street during Friday’s session, with indices and sectors trading in positive territory as investors welcomed the latest...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
10 Health Care Stocks Whale Activity In Today's Session
July 26, 2024
Via
Benzinga
Why Bristol Myers Squibb Jumped Nearly 10% on Friday
July 26, 2024
The pharmaceutical company is faring far better than most investors were anticipating at this point.
Via
The Motley Fool
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 26, 2024
Via
Benzinga
Stocks To Watch Today: 3M, BMY, And Coursera Inc.
July 26, 2024
Several major companies reported quarterly earnings this week, with 3M, Bristol-Myers Squibb, and Coursera Inc. seeing significant stock price gains.
Via
Talk Markets
Bristol Myers Squibb (BMY) Q2 2024 Earnings Call Transcript
July 26, 2024
BMY earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
July 26, 2024
Via
Benzinga
Exposures
Fossil Fuels
BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q2 2024
July 26, 2024
BMY stock results show that Bristol-Myers Squibb beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Norfolk Southern Posts Upbeat Earnings, Joins Newell Brands, Charter Communications, 3M And Other Big Stocks Moving Higher On Friday
July 26, 2024
Via
Benzinga
Bristol Myers Squibb Witnesses Strong Demand For 'Newer Drugs' As Q2 Earnings Beat Expectations, Raises 2024 Profit Forecast
July 26, 2024
Bristol Myers Squibb reported Q2 revenues of $12.2 billion, surpassing the consensus of $11.55B, driven by its Growth Portfolio and Eliquis. The company's adjusted EPS of $2.07 beat expectations of...
Via
Benzinga
Topics
Earnings
Exposures
Financial
US Stocks Look To End Week On High Note As Nvidia Leads Mega-Caps Higher In Premarket Ahead Of Key Inflation Data
July 26, 2024
After the severe pounding the tech space received in the past three sessions, it might be rebound time. However, any recovery will largely hinge on whether key inflation data confirms the continued...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
S&P 500, Nasdaq Settle Lower As Tech Stocks Continue To Falter: Greed Index In 'Fear' Zone
July 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bristol-Myers Squibb, Deckers Outdoor And 3 Stocks To Watch Heading Into Friday
July 26, 2024
Via
Benzinga
DECK, SKX Higher After Earnings; PCE On Tap Friday
July 25, 2024
It’s tough to get a firm handle on this market. One day it looks like a trading rotation into undervalued equities from big run-ups elsewhere, the next day it’s a major selloff across the board.
Via
Talk Markets
2 High-Yield Dividend Stocks Billionaires Are Buying. Are They Right for You?
July 25, 2024
Billionaires are buying these stocks, but that doesn't necessarily make them right for your portfolio.
Via
The Motley Fool
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
July 24, 2024
Guggenheim Partners initiated coverage on Alumis, highlighting its lead asset ESK-001, a TYK2 inhibitor for plaque psoriasis and systemic lupus erythematosus. With upcoming Phase 3 trials and no JAK...
Via
Benzinga
Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
July 23, 2024
Via
Benzinga
AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife
July 23, 2024
The aim is to strengthen their drug pipelines and expand their presence in the world's second-largest pharmaceutical market.
Via
Benzinga
3 Defensive Stocks to Shield Your Portfolio in July
July 20, 2024
Fed Chair Jerome Powell’s cautious economic outlook adds to the allure of defensive stocks offering stable long-term returns
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
7 Value Stocks to Buy at a 52-Week Low in July
July 19, 2024
Bottom fishers and contrarians take note: each of these seven value stocks to buy is on sale after recently hitting new 52-week lows.
Via
InvestorPlace
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
July 21, 2024
The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
46
47
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.